Contents

Search


mirabegron/solifenacin (Myrbetriq/Vesicare)

Indications: - treatment of overactive bladder (FDA-approved May 2018)

General

pharmacologic combination

References

  1. Brown T FDA Approves Mirabegron, Solifenacin Combo for OAB. Medscape - May 09, 2018. https://www.medscape.com/viewarticle/896394

Components

mirabegron (Myrbetriq) solifenacin (Vesicare)